Variable selection-combined causal mediation analysis for continuous treatments with application to large-dimensional biomedical data
PLOS Computational Biology · 24.06.2026 · 22 (6) · e1014436
DOI: 10.1371/journal.pcbi.1014436 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, online erschienen am 24.06.2026. Verfasst von Yajing Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, NHC Key Laboratory for Health Technology Assessment, Key Laboratory of Public Health Safety of Ministry of Education, Sc…. Hauptthemen laut MEDLINE: Mediation Analysis. Die Arbeit nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Talent Programs, Shanghai Municipal Science and Technology Major Project.
Abstract (Originalsprache)
Substantial progress has been made in the area of causal inference utilizing large-scale data, among which the estimation of causal mediation effects has attracted a lot of attention. However, existing large-dimensional causal inference primarily focuses on total effects or typical causal mediation effects under binary variable settings, placing less emphasis on large-scale covariate selection with continuous treatment and mediator. To address this, we propose a weighted semiparametric estimation framework that integrates the generalized outcome-adaptive LASSO method into generalized propensity score modeling to achieve estimation of causal mediation effects under continuous variable settings. Simulation results show that our proposed method outperforms other regularization-based methods in selection accuracy and estimation efficiency, which is achieved by incorporating outcome-related key variables and excluding noise covariates. From the perspective of achieving a stable balance between efficiency and bias, as well as high-dimensional information filtering, our method may serve as a compelling alternative that balances estimation efficiency with model interpretability and inferential robustness. We further conduct a real-world application based on the UK Biobank database, quantifying the causal mediation effects of apolipoprotein B levels within the association between potential diabetes risk and cancer incidence using large-scale healthcare and medical data.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Biostatistics, NHC Key Laboratory for Health Technology Assessment, Key Laboratory of Public Health Safety of Ministry of Education, School of Public Health, Fudan University, Shanghai China.
- Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.
- Shanghai Key Laboratory of Gene Editing and Cell Therapy for Rare Diseases, Fudan University, Shanghai, China.
ORCID-Profile: Yajing Zhou, Yongfu Yu
Förderung
- National Natural Science Foundation of China
- Shanghai Talent Programs
- Shanghai Municipal Science and Technology Major Project
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
Zitieren
APA
Zhou, Y., Wei, K., Liu, Y., Li, Z., Huang, C., Qin, G., & Yu, Y. (2026). Variable selection-combined causal mediation analysis for continuous treatments with application to large-dimensional biomedical data. PLOS Computational Biology, 22(6), e1014436. https://doi.org/10.1371/journal.pcbi.1014436
Vancouver
Zhou Y, Wei K, Liu Y, Li Z, Huang C, Qin G, et al. Variable selection-combined causal mediation analysis for continuous treatments with application to large-dimensional biomedical data. PLOS Computational Biology. 2026;22(6):e1014436. doi:10.1371/journal.pcbi.1014436
BibTeX
@article{Zhou2026,
author = {Zhou, Yajing and Wei, Kecheng and Liu, Yahang and Li, Zhaoyang and Huang, Chen and Qin, Guoyou and Yu, Yongfu},
title = {Variable selection-combined causal mediation analysis for continuous treatments with application to large-dimensional biomedical data},
journal = {PLOS Computational Biology},
year = {2026},
volume = {22},
number = {6},
pages = {e1014436},
doi = {10.1371/journal.pcbi.1014436}
}
EUVIMED